Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Trial of PCV24 in Adults Aged 18 and Older
NCT06678620Phase 2Completed
- Sponsor
- Shanghai Reinovax Biologics Co., Ltd.
- Start
- Apr 2024
- Primary completion
- Dec 2024
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Reinovax PCV24 in pneumococcal infection, sponsored by Shanghai Reinovax Biologics Co., Ltd.. Started Apr 2024; status: completed.
02
Drugs
Reinovax PCV24
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT06678620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06678620.